Capital Markets Day

Capital Markets Day

December 7th 2022 | New York City and Virtual

Setting out Indivior's roadmap for delivering long-term shareholder value

Indivior is a global pharmaceutical company working to help change patients’ lives by pioneering life-transforming treatment for substance use disorders and other serious mental illnesses. To register for the in-person event, please email

Virtual webcast link can be found by accessing the "Event Materials" tab. 


Please see an overview of the event. More information will be released nearer to the event date

  • When: Wednesday, December 7th, 2022 (8:30 AM to 12:30 PM US Eastern)
  • What: Investor event setting out Indivior's roadmap for delivering long-term shareholder value
  • Where: New York City and Virtual webcast 
  • Register: For in-person event email For virtual participation, please see "Event Materials" tab for link. 
  • 8:30 - Welcome
  • 8:35 - Company Overview & Strategy - Mark Crossley, CEO
  • 9:00 - SUBLOCADE® - Richard Simkin, Chief Commercial Officer, Vishal Kalia, SVP, US Treatment Access, Support Programs and Business Insights, Dr. Terry Horton, VP, Patient Insights and Advocacy
  • 10:15 - Q&A
  • 10:30 - Break
  • 10:45 - PERSERIS® - Glenn Tyson, SVP, Sales & Marketing
  • 11:10 - R&D Pipeline - Dr. Christian Heidbreder, Chief Scientific Officer
  • 11:40 - ESG and Sustainability - Nina DeLorenzo, Chief Global Impact Officer
  • 11:55 - Operational Excellence - Ryan Preblick, CFO
  • 12:15 - Closing Remarks and Q&A

To register or for more information please contact